San Diego, CA -- (SBWire) -- 07/23/2020 --An investigation on behalf of investors in shares of 9 Meters Biopharma, Inc. (NASDAQ: NMTR) was announced over potential breaches of fiduciary duties by certain officers and directors at 9 Meters Biopharma, Inc..
Investors who purchased shares of 9 Meters Biopharma, Inc. (NASDAQ: NMTR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain 9 Meters Biopharma, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Raleigh, NC based 9 Meters Biopharma, Inc., a gastrointestinal platform company, focuses on patients with rare disorders and unmet needs. 9 Meters Biopharma, Inc. reported that its Net Loss increased from $24.16 million in 2018 to $27.04 million in 2019.
Shares of 9 Meters Biopharma, Inc. (NASDAQ: NMTR) declined from $0.90 per share in November 2019 to as low as$ $0.45 per share in May 2020.
On July 22, 2020, NASDAQ: NMTR shares closed at $05.1 per share.
Those who purchased shares of 9 Meters Biopharma, Inc. (NASDAQ: NMTR), have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
9 Meters Biopharma, Inc. (NASDAQ:NMTR) Investor Alert: Investigation over Potential Wrongdoing
An investigation on behalf of investors in 9 Meters Biopharma, Inc. (NASDAQ:NMTR) shares over potential wrongdoing at 9 Meters Biopharma, Inc. was announced and NASDAQ:NMTR stockholders should contact the Shareholders Foundation.